Meng Yu
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
Meng Yu is currently the Chief Operating Officer & Executive Director at Hightide Therapeutics, Inc., a position held since 2015.
Ms. Yu completed undergraduate studies at the University of Science & Technology of China and graduate studies at the School of Medicine University of Nevada.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2026 | 3.744.699 ( 0,66% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Operationeel Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hightide Therapeutics, Inc.
Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
School of Medicine University of Nevada
School of Medicine University of Nevada Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau